Cell Biology and Immunology Group, Wageningen University & Research, Wageningen, Netherlands.
Host-Microbe Interactomics Group, Wageningen University & Research, Wageningen, Netherlands.
Front Immunol. 2019 Feb 12;10:94. doi: 10.3389/fimmu.2019.00094. eCollection 2019.
Human milk oligosaccharides (HMO) and prebiotic oligosaccharides are proposed to confer several health benefits to the infant. They shape the microbiota, have anti-inflammatory properties, and support epithelial barrier functioning. However, in order to select the best oligosaccharides for inclusion in infant formulas, there is a need to increase our understanding of the specific effects of HMO and prebiotics on the host immune system. Therefore, we investigated the effects of the HMO sialyllactose (SL), and galactooligosaccharides (GOS) on epithelial barrier functioning, microbiota composition, and SCFA production. The effect of GOS and SL on epithelial barrier functioning and microbiota composition was investigated using models. Epithelial barrier function was investigated by transcriptome analysis of fully polarized Caco-2 cells exposed for 6 h to SL or GOS. In addition, epithelial cell growth, alkaline phosphatase production, and re-epithelization was studied. Further, we investigated the effect of SL and GOS on microbiota composition and SCFA production using fecal batch cultures. Transcriptome analysis showed that SL and GOS both induced pathways that regulate cell cycle control. This gene-expression profile translated to a phenotype of halted proliferation and included the induction of alkaline phosphatase activity, a marker of epithelial cell differentiation. SL and GOS also promoted re-epithelialization in an epithelial wound repair assay. SL and GOS did show distinct modulation of microbiota composition, promoting the outgrowth of and bifidobacteria, respectively, which resulted in distinct changes in SCFA production profiles. Our results show that SL and GOS can both modulate epithelial barrier function by inducing differentiation and epithelial wound repair, but differentially promote the growth of specific genera in the microbiota, which is associated with differential changes in SCFA profiles.
人乳寡糖(HMO)和益生元寡糖被认为能为婴儿提供多种健康益处。它们能塑造肠道菌群,具有抗炎作用,并支持上皮屏障功能。然而,为了选择最适合添加到婴儿配方奶粉中的寡糖,我们需要增加对 HMO 和益生元对宿主免疫系统的具体影响的理解。因此,我们研究了 HMO 唾液酸乳糖(SL)和半乳糖寡糖(GOS)对上皮屏障功能、微生物群落组成和 SCFA 产生的影响。使用 模型研究了 GOS 和 SL 对上皮屏障功能和微生物群落组成的影响。通过对暴露于 SL 或 GOS 6 小时的完全极化 Caco-2 细胞进行转录组分析来研究上皮屏障功能。此外,还研究了上皮细胞生长、碱性磷酸酶产生和再上皮化。进一步,我们使用 粪便批量培养研究了 SL 和 GOS 对微生物群落组成和 SCFA 产生的影响。转录组分析表明,SL 和 GOS 都诱导了调节细胞周期控制的途径。这种基因表达谱转化为增殖停滞的表型,包括碱性磷酸酶活性的诱导,这是上皮细胞分化的标志物。SL 和 GOS 还在 上皮伤口修复测定中促进了再上皮化。SL 和 GOS 确实表现出对微生物群落组成的不同调节,分别促进了 和双歧杆菌的生长,这导致了 SCFA 产生谱的明显变化。我们的研究结果表明,SL 和 GOS 都可以通过诱导分化和上皮伤口修复来调节上皮屏障功能,但通过促进微生物群落中特定属的生长来差异促进上皮屏障功能,这与 SCFA 谱的差异变化相关。